Phase 3Completed
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
A Randomized Trial Comparing Exenatide With Placebo in Subjects With Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemic Medications
- Sponsor
- AstraZeneca (Industry)
- Enrollment
- 261 enrolled
- Conditions
- Type 2 Diabetes
- Interventions
- placebo; exenatide
- Ages
- adults, older adults
- Registry
- NCT00765817
Full record on ClinicalTrials.gov
From the registry
This study will compare the efficacy and safety of exenatide versus placebo in adults whose diabetes is not fully controlled by insulin glargine with or without metformin and/or pioglitazone.
Primary outcomes
- Change in Glycosylated Hemoglobin (HbA1c)
History
Last registry update
Results first posted
Primary completion
Started
Registered